Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided).
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.
Self-reported Depression and Physical Activity in Adults with Mobility Impairments.
[American Academy of Neurology, Washington, 18-25 April 2015].
Acute transverse myelitis: an unusual complication of typhoid fever.
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
Tetrahydrocannabinol
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Cognitive reserve and symptom experience in multiple sclerosis: A buffer to disability progression over time?
Remyelination Therapy for Multiple Sclerosis.
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort.
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Pages
« first
‹ previous
…
234
235
236
237
238
239
240
241
242
…
next ›
last »